ETF - 美股 | etnet 經濟通|香港新聞財經資訊和生活平台

25,962.73

-426.31

(-1.62%)

25,693

-115

(-0.45%)

低水270

8,691.03

-167.60

(-1.89%)

4,941.14

-135.06

(-2.66%)

3,253.86億

4,135.39

-42.53

(-1.018%)

4,859.59

-55.01

(-1.119%)

15,561.37

-184.37

(-1.171%)

2,838.76

-41.31

(-1.43%)

79,345.1500

-1,744.8500

(-2.152%)

人民幣最佳客戶買入價

1.0954

澳元最佳客戶買入價

5.1002

歐元最佳客戶買入價

9.1168

英鎊最佳客戶買入價

10.4269

日圓最佳客戶買入價

4.9491

／

i

按可檢視更多數據

代號	名稱	貨幣	按盤價	今日升跌	成交金額	市值	1分鐘圖
PGHY	Invesco Global ex-US High Yield Corporate Bond ETF	USD	19.800	-0.478%	26.68萬	2.17億
QVOL	Infrastructure Capital Nasdaq Option Income ETF	USD	99.470	-1.484%	26.69萬	7.57百萬
VBCA	Vanguard Target Maturity 2027 Corporate Bond ETF	USD	75.490	-0.009%	26.69萬	3.32千萬
RNRG	Global X Renewable Energy Producers ETF 創1個月低	USD	37.840	-1.957%	26.71萬	3.11千萬
FFEB	FT Vest U.S. Equity Buffer ETF - February	USD	60.305	-0.454%	26.74萬	13.39億
LULG	Leverage Shares 2X Long Lulu Daily ETF 創52周低	USD	7.090	-1.801%	26.75萬	5.49百萬
ION	ProShares S&P Global Core Battery Metals ETF 創1個月低	USD	60.580	-5.132%	26.76萬	1.92千萬
RSHO	Tema American Reshoring ETF	USD	56.577	-2.849%	26.79萬	2.77億
PALD	Direxion Daily PANW Bear 1X ETF 創52周低	USD	17.420	-0.401%	26.79萬	1.75百萬
ACES	ALPS Clean Energy ETF	USD	37.620	-2.260%	26.84萬	1.30億
MPL	Tidal Trust II Defiance Daily Target 2X Long MP ETF	USD	20.860	2.406%	26.90萬	4.62百萬
GLDY	Defiance Gold Enhanced Options Income ETF 創52周低	USD	14.520	-2.156%	26.97萬	3.34千萬
METL	Sprott Active Metals & Miners ETF	USD	28.415	-5.776%	27.01萬	9.92千萬
AVRE	Avantis Real Estate ETF 創1個月低	USD	46.735	-1.299%	27.18萬	8.01億
INCE	Franklin Templeton ETF Trust	USD	66.432	-0.594%	27.18萬	1.20億
BSMS	Invesco BulletShares 2028 Municipal Bond ETF 創1個月低	USD	23.390	-0.169%	27.19萬	3.02億
CPSF	Calamos S&P 500 Structured Alt Protection ETF February	USD	26.110	-0.115%	27.23萬	3.33千萬
NUEM	Nuveen ESG Emerging Markets Equity ETF	USD	40.775	-2.569%	27.24萬	3.85億
MVV	ProShares Ultra MidCap400	USD	81.245	-3.274%	27.26萬	1.57億
BVAL	Bluemonte Large Cap Value ETF	USD	30.150	-1.051%	27.30萬	2.50億

最新

人氣

etnet TV

財經新聞

評論

專題透視

生活

DIVA

健康好人生

香港好去處